VA
ELV icon

Verdad Advisers’s Elevance Health ELV Stock Holding History

Verdad Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-709
Closed -$208K – 236
2026
Q1 		$208K Buy
+709
New +$233K 0.23% 130
2024
Q3 		$1.63M Buy
3,134
+119
+4% +$63.6K 2.18% 8
2024
Q2 		$1.63M Buy
3,015
+865
+40% +$457K 1.89% 8
2024
Q1 		$1.11M Buy
+2,150
New +$1.07M 1.21% 19

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Verdad Advisers's ELV Position: Q2 2026 in Review

Verdad Advisers sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 709 shares — an estimated $208K sold.

Verdad Advisers first reported a position in ELV in Q1 2024 and held it in 4 quarters. The position peaked at $1.63M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Verdad Advisers reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Verdad Advisers sold 709 Elevance Health shares in Q2 2026, an estimated $208K.
  • Verdad Advisers first reported a position in Elevance Health in Q1 2024 and held it in 4 quarters.
  • Verdad Advisers's Elevance Health position peaked at $1.63M in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.